Nalaganje...
Hairy cell leukemia: present and future directions
Hairy cell leukemia (HCL) is an indolent B-cell malignancy, with long-term responses to purine analogs, but with decreasing efficacy and increasing toxicity with repeated courses. Leukemic cells express CD22, CD20, CD25, tartrate-resistant acid phosphatase (TRAP), annexin 1A (Anxa1), and BRAF V600E...
Shranjeno v:
| izdano v: | Leuk Lymphoma |
|---|---|
| Glavni avtor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7435069/ https://ncbi.nlm.nih.gov/pubmed/31068044 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10428194.2019.1608536 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|